Industry Innovators
BIO is proud to recognize industry leaders within the biotechnology industry. Below are winners of our most significant awards.
Dr. Kakkis is currently Chief Executive Officer, President and Founder of Ultragenyx Pharmaceutical where he leads a team developing and commercializing multiple rare and ultra-rare disease treatments.
Sue Desmond-Hellmann is a physician, scientist and philanthropist, who has devoted her career to improving the human condition. As a pioneer in healthcare for more than 30 years, she’s driven major developments toward the eradication of disease, poverty and inequity.
Sue Desmond-Hellmann, a nonprofit leader and physician in oncology and public health, serves as a senior advisor for GV, BDT, and Lazard. She's on the boards of OpenAI, Pfizer, and National Resilience, as well as Stand Up to Cancer, and the President’s Council of Advisors on Science and Technology.
Bancel has served as Moderna’s chief executive officer since October 2011 and as a member of Moderna’s board of directors since March 2011.
Maraganore served as the founding CEO and a director of Alnylam from 2002 to 2021, where he built and led the company from early platform research on RNA interference through global approval and commercialization of the first four RNAi therapeutic medicines.
The Biotechnology Heritage Award was presented to Ivor Royston, president and CEO of Viracta Therapeutics, Inc., during the BIO International Convention, held June 13–16, 2022, in San Diego.
Dr. Kleiser co-founded Dalan Animal Health in 2019 to develop breakthrough vaccines for honeybees and other invertebrates. There, she helped lead the discovery and launch of the first vaccine for bees and, drawing on her skills in biotech drug development, built scientific evidence to bring the vaccine to market.
Dr. Harris has worked to reduce the time it takes to produce animal vaccines. His discoveries have shaped the way we raise livestock, combat animal disease threats, and protect the nation’s food supply.
Dr. Robert Kennedy work provides growers with novel technologies that overcome resistance issues while being safe for the environment and workers.
Pramod developed Praj’s Bio-Mobility™ platform, which produces renewable liquid and gas biofuels for land, sea, and air transportation, and Bio-Prism™, a portfolio of technologies to produce renewable chemicals and materials from biomass, including bioplastics.
Wulf is the president and CEO of AquaBounty Technologies, Inc., leading commercialization and growth of the world’s first genetically engineered animal approved for food, AquaBounty’s salmon.
Dr. Pam Marrone is the co-founder and executive chair of Invasive Species Corp, in addition to three other biotech companies – Entotech, AgraQuest, and Marrone Bio Innovations.
Under Dr. Tsong’s leadership, Amyris has developed a biotech-based fermentation technology to efficiently convert feedstocks into products and ingredients from vitamin E and squalene to flavors and fragrances.
Emily is the co-founder of San Francisco-based Twist Bioscience, which manufactures DNA and DNA-based products to improve human health and sustainability.
